Pharmacological inhibitors of anaplastic lymphoma kinase (alk) induce immunogenic cell death through on-target effects

HIGHLIGHTS

• who: Adriana Petrazzuolo from the (UNIVERSITY) have published the paper: Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects, in the Journal: Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany). Human NPM1-ALK+ ALCL SUP-M2 and NPM1-ALK-negative (NPM1-ALK-) ALCL MAC-1 and FE-PD cell lines were kindly provided by Dr. Meggetto (Centre de Recherches en Cancérologie de Toulouse, France); human NPM1-ALK+ ALCL SUP-M2 cell line crizotinib-resistant (SUP-M2CR03) [40] by Dr. Ceccon and Prof. Gambacorti-Passerini (Università degli Studi di Milano-Bicocca, Italy . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.